Onxeo Financial Statements From 2010 to 2025

C4X Stock   0.05  0.01  14.29%   
Onxeo SA financial statements provide useful quarterly and yearly information to potential Onxeo SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Onxeo SA financial statements helps investors assess Onxeo SA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Onxeo SA's valuation are summarized below:
Onxeo SA does not presently have any trending fundamental ratios for analysis.
Check Onxeo SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Onxeo SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Onxeo financial statements analysis is a perfect complement when working with Onxeo SA Valuation or Volatility modules.
  
This module can also supplement various Onxeo SA Technical models . Check out the analysis of Onxeo SA Correlation against competitors.

Onxeo SA Company Total Debt Analysis

Onxeo SA's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Onxeo SA Total Debt

    
  9.91 M  
Most of Onxeo SA's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Onxeo SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition
Based on the latest financial disclosure, Onxeo SA has a Total Debt of 9.91 M. This is much higher than that of the sector and significantly higher than that of the Total Debt industry. The total debt for all Germany stocks is notably lower than that of the firm.

Onxeo SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Onxeo SA's current stock value. Our valuation model uses many indicators to compare Onxeo SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Onxeo SA competition to find correlations between indicators driving Onxeo SA's intrinsic value. More Info.
Onxeo SA is rated fourth in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for Onxeo SA is about  10,941,272 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Onxeo SA's earnings, one of the primary drivers of an investment's value.

About Onxeo SA Financial Statements

Onxeo SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Onxeo SA investors may analyze each financial statement separately, they are all interrelated. The changes in Onxeo SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on Onxeo SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Onxeo Stock Analysis

When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.